Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
IndustryARC
www.industryarc.com/
Venkat Reddy
venkat@industryarc.com
(+1) 970-236-3677

Bookmark and Share
In Vitro Diagnostics (IVD) Quality Controls Market - Forecast to 2021 - 2026
The rapid growth of the global geriatric population is anticipated to drive the market for IVD testing and quality control products.

BriefingWire.com, 3/03/2022 - The [FURL=https://www.industryarc.com/Report/16822/in-vitro-diagnostics-ivd-quality-controls-market.html?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]In-Vitro Diagnostics (IVD) Quality Controls Market[/FURL] size is estimated to reach $1,432 million by 2026, growing at a CAGR of 5.6% during the forecast period 2021-2026. In-vitro diagnostic tests are conducted on collected blood tissue samples in order to detect various communicable and non-communicable diseases. Moreover, they can also be used to monitor a patient’s health, cure diseases, and also enable medical professionals to identify the most effective treatment procedure or therapy for the patient. IVQ Quality Controls are products used to evaluate the quality and accuracy of these tests.

Key Takeaways

Geographically, the North American In Vitro Diagnostics (IVD) Quality Controls market accounted for the largest share in 2020 owing to the presence of well-developed healthcare infrastructure and increasing lifestyle diseases in the region.

The growing number of certified clinical laboratories providing IVD diagnostics is driving the market during the forecast period. However, the high cost of IVD quality control products is predicted to hamper growth, especially in developing regions.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the In Vitro Diagnostics (IVD) Quality Controls Report.

Download Sample Report @ [FURL]www.industryarc.com/pdfdownload.php?id=16822[/FURL]

In Vitro Diagnostics (IVD) Quality Controls Market Segment Analysis - By Geography

The In-Vitro Diagnostics (IVD) Quality Controls Market based on Geography can be segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. The North American segment is projected to dominate the In Vitro Diagnostics (IVD) Quality Controls Market during the forecast period 2021-2026 with a market share of 36% owing to the presence of highly developed healthcare infrastructure, growing geriatric population, rising cases of cancer, and high patient awareness regarding the importance of early diagnosis and treatment. Moreover, the growth in the private and public expenditure on R&D is leading to the introduction of more innovative technologies in the region, thereby promoting growth.

In Vitro Diagnostics (IVD) Quality Controls Market Drivers

Increase in Geriatric Population is Projected to Drive Market Growth

The rise in Covid-19 infections is Anticipated to Boost Product Demand

The top 10 companies of the industry include Abbott Laboratories, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche AG, Quidel Corporation, bioMerieux Inc, Qnostics Ltd, Microbiologics Inc, SeraCare Life Sciences Inc, Thermo Fisher Scientific, ZeptoMetrix Corporation.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2025 Proserve Technology, Inc.